Generalist · VC Firm

Redpoint Ventures

A single high-conviction quantum bet, PsiQuantum, dating back to a 2016 Series A co-lead, with no verifiable follow-on since. Generalist firm; the quantum stake is a legacy position (PsiQuantum last valued at $7B post-money, Sept 2025), not a practice.

Active Woodside, United StatesFounded 1999

Investment thesis

Generalist Sand Hill firm (founded 1999) running two tracks: early-stage flagship funds (Fund X, $650M, closed May 2025) and Omega growth funds (Omega V, $740M, closed June 2024).

Was an early and meaningful quantum investor: co-led PsiQuantum's $13.5M Series A in June 2016, years before the market priced fault-tolerant quantum computing.

Holds that single position rather than building a quantum practice: no verifiable follow-on past the Series A, and no second quantum or PQC investment across a 240+ company portfolio.

Core muscle is enterprise software, infrastructure, AI and fintech; quantum exposure is a legacy outlier, not a thesis.

Anti-thesis

The patterns that trigger a fast no with this fund.

  1. Enterprise SaaS and infrastructure DNA; no partner with a quantum or physics background on the 2026 team
  2. No verifiable quantum check since June 2016; not named in PsiQuantum's Series D (2021) or Series E (2025) press releases
  3. The PsiQuantum stake sits in a 2016-vintage fund; the active funds (Fund X, Omega V) show no quantum allocation
  4. Founding generation (Dyal, Brody, Walecka, Yang) has moved to emeritus or out; institutional memory of the 2016 deal has likely thinned
  5. Do not expect proactive quantum sourcing: they do not market the position

Notable quantum portfolio

Full portfolio
PsiQuantum

Frequent co-investors